LFST Stock Analysis: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$12.47
-0.18 (-1.42%)
▼
5d:
+0.4%
30d:
+15.36%
90d:
+67.16%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: LFST shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: LFST shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.19
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.02
17.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $12.47, which is considered extended relative to its 30-day fair value range of $10.61 to $12.12. The stock's valuation (Forward PE: 23.5) is in line with its historical norms (23.4). At these levels, the market is pricing in 0.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LFST is in a strong uptrend. Immediate support is located at $10.85, while resistance sits at $12.96.
Market Sentiment: LFST scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.80 (+10.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LFST is in a strong uptrend. Immediate support is located at $10.85, while resistance sits at $12.96.
Market Sentiment: LFST scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.80 (+10.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.61 -
$12.12
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($13.80)
- NEUTRAL: Market pricing in 0.1% annual earnings growth - fairly valued
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.61 -
$12.12
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.85
Resistance Level
$12.97
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.49
Wall Street Target
$13.80
(+10.7%)
Revenue Growth (YoY)
26.1%
Earnings Growth (YoY)
1927.5%
Profit Margin
3.2%
Valuation Premium vs History
+0.1% premium
PE vs Historical
23.5 vs 23.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.1%
(market-implied from PE analysis)
1-Year Target
$12.48
(+0%)
2-Year Target
$12.49
(+0%)
3-Year Target
$12.51
(+0%)
3-Yr Target (if PE normalizes)
(PE: 23→23)
PE COMPRESSION
$12.46
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.5, Growth: 34.2%)
$30.15
(+142%)
Base:
(SPY PE: 20.1, Growth: 34.2%)
$25.75
(+107%)
Bear:
(PE: 17.1, Growth: 34.2%)
$21.89
(+76%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (97x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 97.31 | Current EPS (TTM): $0.13
Bull Case
$27.83
(+123%)
Analyst growth 100.0%, PE expands to 107.0
Base Case
$25.30
(+103%)
Market implied 100.0%, PE stable at 97.3
Bear Case
$8.60
(-31%)
Severe decline -20.0%, PE contracts to 82.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 7:48 PM ET
Data refreshes hourly during market hours. Next update: 8:48 PM
Data refreshes hourly during market hours. Next update: 8:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Bessler
SELL
5101 shares
2026-04-21
Darren M Black
SELL
4314939 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
